LATISSE is a new prescription eyelash growth treatment, produced by Allergan, maker of Botox and leading global medical aesthetics company. The FDA recently approved LATISSE (bimatoprost ophthalmic solution) 0.03% for treatment of inadequate or insufficient eyelashes. LATISSE acts to help eyelashes grow longer, fuller and darker. LATISSE is the first science-based and clincally validated eyelash growth treatment.
LATISSE is an easy-to-use treatment that is used once-daily by applying the treatment to the base of the upper eyelashes (like eyeliner) with a sterile single-use-per-eye disposable applicator. In as little as eight weeks, LATISSE users can expect to experience longer, fuller and darker eyelashes, with significant results in 16 weeks.
More about LATISSE prescription eyelash growth treatment after the jump...
Continue reading "LATISSE Prescription Eyelash Growth Treatment from Allergan" »
